Summary & Key Points
"Early on, the PAC-CI Program focused on a major public health issue: mother-to-child transmission of HIV. At a time when access to treatments remained limited, this form of transmission was a significant concern for healthcare providers, families, and health systems."
PAC-CI has long placed child protection at the heart of its research
Early on, the PAC-CI Programme focused on a major public health issue: the transmission of HIV from mother to child.
At a time when access to treatment was still limited, this form of transmission was a major concern for healthcare providers, families, and health systems. Pregnancy, childbirth, and breastfeeding were particularly sensitive periods, requiring tailored responses to better protect newborns.
In response to this challenge, PAC-CI made child protection a key focus of its research. This commitment led to the conduct of two pioneering trials: DITRAME and DITRAME+.
Through these studies, the Programme contributed to the search for practical solutions to better understand how to reduce the risk of mother-to-child HIV transmission in our context.
In our next article, learn how the DITRAME and DITRAME+ trials helped advance strategies for preventing mother-to-child transmission of HIV.
Christian Kouadio
Clinical Research Associate and Communications Manager at PAC-CI
Contact the author
